Intracranial thrombus composition is associated with occlusion location and endovascular treatment outcomes: results from ITACAT multicenter study (2024)

1. http://orcid.org/0000-0003-1309-0730Jesus Juega1,
2. http://orcid.org/0000-0002-5671-6484Manuel Requena1,2,
3. http://orcid.org/0000-0001-7316-6202Carlos Piñana2,
4. Maite Rodriguez1,
5. Jessica Camacho3,
6. Marta Vidal3,
7. Teresa Moliné3,
8. Garazi Serna4,
9. Carlos Palacio-Garcia5,
10. http://orcid.org/0000-0001-8100-9477Marta Rubiera1,
11. http://orcid.org/0000-0003-3633-3002Alvaro Garcia-Tornel1,
12. Noelia Rodriguez-Villatoro1,
13. David Rodriguez-Luna1,
14. Marian Muchada1,
15. http://orcid.org/0000-0003-4637-1598Marta Olive Gadea1,
16. http://orcid.org/0000-0002-5945-8222Federica Rizzo1,
17. http://orcid.org/0000-0002-7953-3795Marc Rodrigo-Gisbert1,
18. Carlos Lazaro1,
19. David Hernandez2,
20. Marta de Dios Lascuevas2,
21. http://orcid.org/0000-0002-3245-917XFrancesco Diana2,
22. Laura Dorado6,
23. http://orcid.org/0000-0001-8279-7954María Hernández-Pérez6,
24. Helena Quesada7,
25. Pere Cardona Portela7,
26. Carolina De La Torre8,
27. Santiago Ramon-y-Cajal3,
28. http://orcid.org/0000-0002-6736-1535Alejandro Tomasello2,
29. http://orcid.org/0000-0001-9242-043XMarc Ribo1,2,
30. Carlos A Molina1,
31. Jorge Pagola1

1. ¹Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital. Autonomous University of Barcelona. Vall d’Hebron Research Institute, Barcelona, Spain
2. ²Interventional Neuroradiology, Vall d’Hebron University Hospital, Barcelona, Barcelona, Spain
3. ³Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain
4. ⁴Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain
5. ⁵Hematology Department, Vall d’Hebron University Hospital, Barcelona, Spain
6. ⁶Stroke Unit. Department of Neurology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
7. ⁷Stroke Unit, Department of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain
8. ⁸Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Spain

1. Correspondence to Dr Jesus Juega, Stroke Unit, Department of Neurology, Vall d’Hebron Hospital, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain; jesusmjuega{at}gmail.com

• Platelets
• Stroke
• Thrombectomy

• Platelets
• Stroke
• Thrombectomy

Footnotes

• X @marcriboj

• Contributors JP is the guarantor. Conception and design: JJ, MR, and JP. Acquisition of the data: all authors. Analysis and interpretation of the data: JJ, JC, MR, and JP. Drafting the article: JJ, MR, and JP. Critically revising the article: all authors. Approved the final version of the manuscript: all authors.

• Funding This work was supported by project 355/C/2017, Fundació La Marató de TV3 on strokes and traumatic spinal cord and brain injury, 2017 call of projects.

• Competing interests MR reported receiving personal fees from Anaconda Biomed, AptaTargets, Cerenovus, Johnson & Johnson, Medtronic, Methinks, Philips, Sanofi, Stryker, and Rapid AI outside the submitted work.

• Provenance and peer review Not commissioned; externally peer reviewed.

• Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.